-
公开(公告)号：KR100804311B1
公开(公告)日：2008-02-18
申请号：KR1020060061169
申请日：2006-06-30
Applicant: 대한민국 (식품의약품안전처장)
IPC: A61K31/352 , A61P25/30
Abstract: 본 발명은 바이칼린(baicalin)을 유효성분으로 하고, 약제학적으로 허용되는 담체를 포함하는 약물남용 치료제에 관한 것이다. 본 발명의 바이칼린을 유효성분으로 하는 약물남용 치료제는 마약성 진통제 또는 마약의 투여에 의하여 형성되는 약물 의존성을 유의적으로 억제할 수 있으므로, 안전하고 효과적인 약물남용의 치료에 널리 활용될 수 있을 것이다.
약물남용, 약물의존성, 바이칼린, baicalin-
公开(公告)号：KR100749931B1
公开(公告)日：2007-08-17
申请号：KR1020060061182
申请日：2006-06-30
Applicant: 대한민국 (식품의약품안전처장)
IPC: A61K31/7048 , A61P25/30
Abstract: A therapeutic agent for drug abuse and addiction comprising saikosaponin A as an active ingredient is provided to suppress drug dependency formed by administration of narcotic analgesics or narcotics and treat drug abuse and addiction safely. The therapeutic agent for drug abuse and addiction comprises saikosaponin A isolated from Bupleuri radix as an active ingredient and pharmaceutically acceptable carriers, wherein the saikosaponin A is isolated from the Bupleuri radix containing saikosaponin A, B, C and D, alpha-spinasterol, stigmasterol, bupleurmol and eugenol through hot water extraction and suppresses head twitch response in mouse induced by drug abuse and addiction.
Abstract translation: 提供含有柴胡皂苷A作为活性成分的药物滥用和成瘾治疗剂，以抑制由麻醉止痛药或麻醉药的给药形成的药物依赖性，并安全地治疗药物滥用和成瘾。 用于药物滥用和成瘾的治疗剂包含从柴胡中分离的柴胡皂苷A作为活性成分和药学上可接受的载体，其中柴胡皂苷A是从含柴胡皂苷A，B，C和D的柴胡根中分离得到的，α-菠菜甾醇，豆甾醇， bupleurmol和丁香酚通过热水提取并且抑制药物滥用和成瘾引起的小鼠头部抽搐反应。
-
Patent Agency Ranking
公开(公告)号：KR1020080002367A
公开(公告)日：2008-01-04
申请号：KR1020060061169
申请日：2006-06-30
Applicant: 대한민국 (식품의약품안전처장)
IPC: A61K31/352 , A61P25/30
Abstract: A therapeutic agent comprising baicalin is provided to inhibit and treat drug abuse and addiction formed by administration of narcotic anodynes or narcotics, and improve safety and efficiency of drug abuse treatment, so that it is useful for inhibition of drug abuse and addiction symptoms including place dependence, crawling behavior and head-twitch. A therapeutic agent for drug abuse and addiction formed by administration of narcotic anodynes or narcotics comprises baicalin extracted from Scutellariae radix extract as an effective ingredient, wherein the narcotic anodynes or narcotics include serotonin causing head-twitch behavior or morphine causing place dependence; the Scutellariae radix extract is prepared by extracting Scutellariae radix with hot water; the therapeutic agent inhibits head-twitch caused by serotonin; and the daily dosage of the baicalin is 8-16 mg/kg.
Abstract translation: 提供包含黄芩苷的治疗剂以抑制和治疗通过施用麻醉药物或麻醉药物形成的药物滥用和成瘾，并且提高药物滥用治疗的安全性和效率，从而可用于抑制药物滥用和成瘾症状，包括地方依赖 爬行行为和头痛。 通过施用麻醉药物或麻醉剂形成的药物滥用和成瘾的治疗剂包括从黄芩提取物中提取的黄芩苷作为有效成分，其中麻醉药物或麻醉剂包括引起头痉挛行为的5-羟色胺或导致地方依赖的吗啡吗啡。 通过用热水提取黄芩制备黄芩提取物; 治疗剂可抑制5-羟色胺引起的头颤; 黄芩苷的日剂量为8-16mg / kg。
-
公开(公告)号：KR100899901B1
公开(公告)日：2009-05-29
申请号：KR1020080105094
申请日：2008-10-27
Applicant: 대한민국 (식품의약품안전처장)
CPC classification number: B65D51/245 , B65D2203/10
Abstract: 본 발명은 무선인식태그가 내장된 용기 뚜껑에 관한 것으로, 보다 상세하게는, 용기 내에 저장된 물질의 정보관리, 재고관리, 사용내역관리 및 위험관리 등 전반적인 물질관리를 용이하게 수행하기 위하여 내부에 무선인식태그를 장착 및 탈착할 수 있도록 구성된 용기 뚜껑에 관한 것이다.
본 발명에 따른 용기 뚜껑은, 무선인식태그가 내장된 용기 뚜껑으로서, 용기의 상부 개구를 덮는 메인바디와; 상기 메인바디의 상부에 돌출 형성되고 무선인식태그가 삽입 장착될 수 있도록 상부가 개구되고 내부에 수용공간이 형성되는 태그장착마운팅과; 상기 태그장착마운팅 내부에서 무선인식태그를 파지하여 유동없이 고정 지지하는 태그홀더와; 상기 태그장착마운팅의 상부 개구를 덮는 커버부재를 포함한다.
용기, 뚜껑, 무선인식태그-
公开(公告)号：KR100804312B1
公开(公告)日：2008-02-18
申请号：KR1020060061176
申请日：2006-06-30
Applicant: 대한민국 (식품의약품안전처장)
IPC: A61K31/352 , A61P25/30
Abstract: 본 발명은 바이칼레인(baicalein)을 유효성분으로 하고, 약제학적으로 허용되는 담체를 포함하는 약물남용 치료제에 관한 것이다. 본 발명의 바이칼레인을 유효성분으로 하는 약물남용 치료제는 마약성 진통제 또는 마약의 투여에 의하여 형성되는 약물 의존성을 유의적으로 억제할 수 있으므로, 안전하고 효과적인 약물남용의 치료에 널리 활용될 수 있을 것이다.
약물남용, 약물의존성, 바이칼레인, baicalein-
公开(公告)号：KR100818795B1
公开(公告)日：2008-04-03
申请号：KR1020070124198
申请日：2007-12-03
Applicant: 대한민국 (식품의약품안전처장)
CPC classification number: G06Q10/087
Abstract: A system for managing reagents with RFID(Radio Frequency IDentification) is provided to perform general reagent management such as information, usage, stock, and expiration management, and manage storage location and safety of each reagent in the lab by using the RFID. A storage ID tag(100) is attached to a reagent storage(1) of a lab, and stores an ID code for identifying the reagent storage and a list of the reagents stored in the reagent storage. A reagent ID tag(200) is attached to a lid of a reagent bottle(5) stored in the reagent storage, and stores the ID code of the reagent storage for storing the reagent and information related to the reagent. A portable terminal(300) receives/outputs the ID code of the reagent storage, the reagent list, and the reagent information stored in the reagent storage ID tag and the reagent ID tag by including an RFID reader. A reagent management server(400) receives/stores information recognized by the portable terminal through the network, manages usage/storage of each reagent, issues a warning for an incorrect storage location by checking the storage location of each reagent bottle, issues the warning for emergency, and provides emergency management information.
Abstract translation: 提供用于管理RFID试剂的系统（射频识别），以进行一般试剂管理，如信息，使用，库存和到期管理，并通过使用RFID管理实验室中每种试剂的存储位置和安全性。 存储ID标签（100）附接到实验室的试剂库（1），并且存储用于识别试剂储存器的ID代码和存储在试剂储存器中的试剂列表。 将试剂ID标签（200）附着到存储在试剂库中的试剂瓶（5）的盖上，存储试剂储存用的试剂储存库的ID码和与试剂有关的信息。 便携式终端（300）通过包括RFID阅读器来接收/输出存储在试剂储存ID标签和试剂ID标签中的试剂存储的ID码，试剂列表和试剂信息。 试剂管理服务器（400）通过网络接收/存储由便携式终端识别的信息，管理每种试剂的使用/存储，通过检查每个试剂瓶的存储位置对不正确的存储位置发出警告，发出警告 紧急情况，并提供应急管理信息。
-
公开(公告)号：KR1020080002374A
公开(公告)日：2008-01-04
申请号：KR1020060061176
申请日：2006-06-30
Applicant: 대한민국 (식품의약품안전처장)
IPC: A61K31/352 , A61P25/30
Abstract: An agent comprising baicalein is provided to inhibit occurrence of symptoms including place dependence, crawling behavior and head-twitch, caused by drug abuse and addiction without side effects, so that the drug abuse and addiction is treated. An agent comprising baicalein obtained from the extract of Scutellariae radix, which is prepared by extracting with hot water, treats drug abuse and addiction formed by administration of narcotic anodynes or narcotics, especially inhibits crawling behavior and place dependence formed by administering apomorphine and cocaine, respectively, wherein the daily dosage of bicalein is 8-16 mg/kg.
Abstract translation: 提供包含黄芩素的药剂，以抑制药物滥用和成瘾引起的地方依赖性，爬行行为和头痛等症状的发生，而没有副作用，从而治疗药物滥用和成瘾。 通过由热水提取制备的黄芩提取物的黄芩苷的药剂治疗药物滥用和通过施用麻醉药物或麻醉剂形成的成瘾药物，特别是抑制爬行行为和放置通过施用阿朴吗啡和可卡因形成的依赖性 其中白蛋白的日剂量为8-16mg / kg。
-
-
-
-
-
-
Search Results
7
records
(took 0.018 seconds)
